Resistin Enhances Monocyte Chemoattractant Protein-1 Production in Human Synovial Fibroblasts and Facilitates Monocyte Migration.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
2019
Historique:
received: 15 11 2018
accepted: 05 03 2019
entrez: 8 3 2019
pubmed: 8 3 2019
medline: 16 3 2019
Statut: ppublish

Résumé

The adipocyte-secreting adipokine, resistin, may play a critical role in the modulation of inflammatory diseases. Migration and infiltration of mononuclear cells into inflammatory sites are critical events during the development of osteoarthritis (OA). Monocyte chemoattractant protein-1 (MCP-1), also known as chemokine ligand 2 (CCL2), plays a critical role in the regulation of monocyte migration and infiltration. In this study, we show how resistin promotes MCP-1 expression in OA synovial fibroblasts and monocyte migration. We used qPCR to detect MCP-1 and miRNA expression. THP-1 migration was investigated by Transwell assay. The Western blotting was used to examine the resistinmediated signaling pathways. Resistin activated the phosphatidylinositol-3-kinase (PI3K), Akt and mammalian target of rapamycin (mTOR) signaling pathways, while PI3K, Akt and mTOR inhibitors or small interfering RNAs diminished resistin-induced MCP-1 expression and monocyte migration. We also demonstrate that resistin stimulates MCP-1mediated monocyte migration by suppressing microRNA (miR)-33a and miR-33b via the PI3K, Akt and mTOR signaling pathways. These results provide new insights into the mechanisms of resistin action that may have therapeutic implications for patients with OA.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
The adipocyte-secreting adipokine, resistin, may play a critical role in the modulation of inflammatory diseases. Migration and infiltration of mononuclear cells into inflammatory sites are critical events during the development of osteoarthritis (OA). Monocyte chemoattractant protein-1 (MCP-1), also known as chemokine ligand 2 (CCL2), plays a critical role in the regulation of monocyte migration and infiltration. In this study, we show how resistin promotes MCP-1 expression in OA synovial fibroblasts and monocyte migration.
METHODS METHODS
We used qPCR to detect MCP-1 and miRNA expression. THP-1 migration was investigated by Transwell assay. The Western blotting was used to examine the resistinmediated signaling pathways.
RESULTS RESULTS
Resistin activated the phosphatidylinositol-3-kinase (PI3K), Akt and mammalian target of rapamycin (mTOR) signaling pathways, while PI3K, Akt and mTOR inhibitors or small interfering RNAs diminished resistin-induced MCP-1 expression and monocyte migration. We also demonstrate that resistin stimulates MCP-1mediated monocyte migration by suppressing microRNA (miR)-33a and miR-33b via the PI3K, Akt and mTOR signaling pathways.
CONCLUSION CONCLUSIONS
These results provide new insights into the mechanisms of resistin action that may have therapeutic implications for patients with OA.

Identifiants

pubmed: 30845380
doi: 10.33594/000000029
doi:

Substances chimiques

3' Untranslated Regions 0
Antagomirs 0
Chemokine CCL2 0
MicroRNAs 0
Phosphoinositide-3 Kinase Inhibitors 0
RNA, Small Interfering 0
Recombinant Proteins 0
Resistin 0
MTOR protein, human EC 2.7.1.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-420

Subventions

Organisme : Taiwan's Ministry of Science and Technology
ID : 105-2320-B-039-015-MY3
Pays : Taiwan
Organisme : China Medical University
ID : CMU106-S-27
Pays : China
Organisme : MacKay Memorial Hospital
ID : MMH-107-55, MMH-108-53
Pays : Taiwan
Organisme : Mackay Medical College
ID : MMC-1071B27
Pays : Taiwan

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors have no financial or personal relationships that could inappropriately influence this research.

Auteurs

Wei-Cheng Chen (WC)

Ph.D. Degree Program of Biomedical Science and Engineering, National Chiao Tung University, Hsinchu, Taiwan.
Department of Orthopaedics, MacKay Memorial Hospital, Taipei, Taiwan.

Shih-Wei Wang (SW)

Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.

Chih-Yang Lin (CY)

Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.

Chun-Hao Tsai (CH)

Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan.

Yi-Chin Fong (YC)

Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin, Taiwan.

Ting-Yi Lin (TY)

Department of Orthopaedics, MacKay Memorial Hospital, Taipei, Taiwan.

Shun-Long Weng (SL)

Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Department of Obstetrics and Gynaecology, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.

Hsien-Da Huang (HD)

Warshel Institute For Computational Biology, The Chinese University of Hong Kong, Shenzhen, China.
School of Life and Health Science, The Chinese University of Hong Kong, Shenzhen, China.
School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, China.

Kuang-Wen Liao (KW)

Ph.D. Degree Program of Biomedical Science and Engineering, National Chiao Tung University, Hsinchu, Taiwan.
Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu, Taiwan.
Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan, liaonms@pchome.com.tw.

Chih-Hsin Tang (CH)

Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan.
Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan.
Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan, chtang@mail.cmu.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH